367 related articles for article (PubMed ID: 17917875)
1. Adoptive immunotherapy of HCMV infection.
Kapp M; Tan SM; Einsele H; Grigoleit G
Cytotherapy; 2007; 9(8):699-711. PubMed ID: 17917875
[TBL] [Abstract][Full Text] [Related]
2. Generation of cytotoxic T lymphocytes specific for human cytomegalovirus using dendritic cells in vitro.
Cho HI; Han H; Kim CC; Kim TG
J Immunother; 2001; 24(3):242-9. PubMed ID: 11394502
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
Peggs KS; Mackinnon S
Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
[TBL] [Abstract][Full Text] [Related]
4. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
[TBL] [Abstract][Full Text] [Related]
5. Generation of HCMV-specific T-cell lines from seropositive solid-organ-transplant recipients for adoptive T-cell therapy.
Brestrich G; Zwinger S; Roemhild A; Noutsias M; Rohde M; Keeren K; Sawitzki B; Volk HD; Reinke P; Hammer MH
J Immunother; 2009; 32(9):932-40. PubMed ID: 19816188
[TBL] [Abstract][Full Text] [Related]
6. Major contribution of codominant CD8 and CD4 T cell epitopes to the human cytomegalovirus-specific T cell repertoire.
Nastke MD; Herrgen L; Walter S; Wernet D; Rammensee HG; Stevanović S
Cell Mol Life Sci; 2005 Jan; 62(1):77-86. PubMed ID: 15619009
[TBL] [Abstract][Full Text] [Related]
7. Detection of human cytomegalovirus-specific T lymphocytes in human blood: comparison of two methods.
Schermann CM; Fischer G; Witt V; Kurz M; Potschger U; Fritsch G
Cytotherapy; 2008; 10(8):834-41. PubMed ID: 19016371
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts.
Riddell SR
Semin Respir Infect; 1995 Dec; 10(4):199-208. PubMed ID: 8668847
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer for activation of CMV specific T cells.
André-Schmutz I; Dal Cortivo L; Hamel Y; Cavazzana-Calvo M
Hum Immunol; 2004 May; 65(5):565-70. PubMed ID: 15172458
[TBL] [Abstract][Full Text] [Related]
10. Generation of Cytotoxic T Lymphocytes Specific for Human Cytomegalovirus Using Dendritic Cells In Vitro.
Cho HI; Han H; Kim CC; Kim TG
J Immunother (1991); 2001 May; 24(3):242-249. PubMed ID: 11395640
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo expansion of human cytomegalovirus-specific cytotoxic T cells by recombinant polyepitope: implications for HCMV immunotherapy.
Rist M; Cooper L; Elkington R; Walker S; Fazou C; Tellam J; Crough T; Khanna R
Eur J Immunol; 2005 Mar; 35(3):996-1007. PubMed ID: 15726667
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T cell immunity to human cytomegalovirus glycoprotein B.
Hopkins JI; Fiander AN; Evans AS; Delchambre M; Gheysen D; Borysiewicz LK
J Med Virol; 1996 Jun; 49(2):124-31. PubMed ID: 8991935
[TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
[TBL] [Abstract][Full Text] [Related]
14. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells.
Boppana SB; Britt WJ
Virology; 1996 Aug; 222(1):293-6. PubMed ID: 8806513
[TBL] [Abstract][Full Text] [Related]
15. Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells.
Mackinnon S; Thomson K; Verfuerth S; Peggs K; Lowdell M
Blood Cells Mol Dis; 2008; 40(1):63-7. PubMed ID: 17869548
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation.
Micklethwaite K; Hansen A; Foster A; Snape E; Antonenas V; Sartor M; Shaw P; Bradstock K; Gottlieb D
Biol Blood Marrow Transplant; 2007 Jun; 13(6):707-14. PubMed ID: 17531781
[TBL] [Abstract][Full Text] [Related]
17. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
Rölle A; Olweus J
APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
[TBL] [Abstract][Full Text] [Related]
19. Infusion of cytomegalovirus specific cytotoxic T lymphocytes from a sero-negative donor can facilitate resolution of infection and immune reconstitution.
Horn B; Bao L; Dunham K; Stamer M; Adler S; Cowan M; Lucas K
Pediatr Infect Dis J; 2009 Jan; 28(1):65-7. PubMed ID: 19034064
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor.
Grigoleit GU; Kapp M; Hebart H; Fick K; Beck R; Jahn G; Einsele H
J Infect Dis; 2007 Sep; 196(5):699-704. PubMed ID: 17674311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]